Insight Molecular Diagnostics Inc (LTS:0KCC)
$ 4.26 -0.10 (-2.29%) Market Cap: 147.26 Mil Enterprise Value: 132.13 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 49/100

Q2 2026 Insight Molecular Diagnostics Inc Earnings Call Transcript

Aug 10, 2026 / 09:00PM GMT
Release Date Price: $4.84 (+0.30%)
Gabrielle Woody Insight Molecular Diagnostics Inc.;Executive Assistant and Human Resources Coordinator.;Joshua Riggs
Insight Molecular Diagnostics Inc - President, Chief Executive Officer,

Welcome, agents. Before turning the call over to Josh Riggs, I would like to review our safe harbor. The company will make projections and forward-looking statements regarding future events. Any statements that are not historical facts are forward-looking statements. These statements are made pursuant to and within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We encourage you to review the company's SEC filings, including the company's most recent Form 10-K and subsequent Form 10-Q, which identify risks and uncertainties that may cause future actual results or events to differ materially. Please note the forward-looking statements made during today's call speak only to the date they are made, and Insight Molecular Diagnostics undertakes no obligation to update them. With that, I would like to now turn the call over to Josh Riggs.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot